Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Slavina B Goleva und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Antihypertensive Agents, Healthcare Disparities, Hypertension, Practice Patterns, Physicians'. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Variability in drug effectiveness and provider prescribing patterns have been reported in different racial and ethnic populations. We sought to evaluate antihypertensive drug effectiveness and prescribing patterns among self‐identified Hispanic/Latino (Hispanic), Non‐Hispanic Black (Black), and Non‐Hispanic White (White) populations that enrolled in the NIH All of Us Research Program, a US longitudinal cohort. We employed a self‐controlled case study method using electronic health record and survey data from 17,718 White, Hispanic, and Black participants who were diagnosed with essential hypertension and prescribed at least one of 19 commonly used antihypertensive medications. Effectiveness was determined by calculating the reduction in systolic blood pressure measurements after 28 or more days of drug exposure. Starting systolic blood pressure and effectiveness for each medication were compared for self‐reported Black, Hispanic, and White participants using adjusted linear regressions. Black and Hispanic participants were started on antihypertensive medications at significantly higher SBP than White participants in 13 and 7 out of 19 medications, respectively. More Black participants were prescribed multiple antihypertensive medications (58.46%) than White (52.35%) or Hispanic (49.9%) participants. First‐line HTN medications differed by race and ethnicity. Following the 2017 American College of Cardiology and the American Heart Association High Blood Pressure Guideline release, around 64% of Black participants were prescribed a recommended first‐line antihypertensive drug compared with 76% of White and 82% of Hispanic participants. Effect sizes suggested that most antihypertensive drugs were less effective in Hispanic and Black, compared with White, participants, and statistical significance was reached in 6 out of 19 drugs. These results indicate that Black and Hispanic populations may benefit from earlier intervention and screening and highlight the potential benefits of personalizing first‐line medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Health and Society, University of Toronto Scarborough, Toronto, Ontario, Canada.
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Division of Medical Genetics and Genomic Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Cohort Analytics Core, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
- All of Us Research Program, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Slavina B Goleva, Ariel Williams, Jacob M Keaton, Tam C Tran, Bennett J Waxse, Tracey M Ferrara, Thomas Cassini, Huan Mo, Joshua C Denny
Förderung
- NIH HHS
- Intramural NIH HHS
Zitieren
APA
Goleva, S. B., Williams, A., Schlueter, D. J., Keaton, J. M., Tran, T. C., Waxse, B. J., Ferrara, T. M., Cassini, T., Mo, H., & Denny, J. C. (2024). Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3360
Vancouver
Goleva SB, Williams A, Schlueter DJ, Keaton JM, Tran TC, Waxse BJ, et al. Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3360
BibTeX
@article{Goleva2024,
author = {Goleva, Slavina B and Williams, Ariel and Schlueter, David J and Keaton, Jacob M and Tran, Tam C and Waxse, Bennett J and Ferrara, Tracey M and Cassini, Thomas and Mo, Huan and Denny, Joshua C},
title = {Racial and Ethnic Disparities in Antihypertensive Medication Prescribing Patterns and Effectiveness},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3360}
}
EUVIMED